Provenge Demonstrates 13 Month Survival Advantage in Low PSA Patients

[Anonymous]

This is more than double the survival advantage shown in any trial for Zytiga or MDV-3100. Provenge also has the lowest side effects of the 3 drugs. With time many patients and MDs will seek out provenge and Dendreon will do well by patients and financially.

http://www.xconomy.com/seattle/2012...best-for-early-stage-patients-scientists-say/

 

[Anonymous]

Here is the medical abstract that was presented at ASCO demonstrating the 13 month survival benefit for low PSA patients:

http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=114&abstractID=94325

 

[Anonymous]

Dendreon Demonstrates 6 months survival on Current Cash before another dilution....

 

[Anonymous]

Sad that people need to interject a lie into a conversation about a true cancer breakthrough.

 

[Anonymous]

I wouldn't be crowing about this data. Even if the the data is accurate, which I believe it is, it will shrink the number of patients getting treated. This is the last thing Dendreon needs! Great, better survival in a smaller population! Perfect story for competitors to feast on.

 

[Anonymous]

Provenge for less advanced patients will eventually multiply the available patient pool. You start with the most advanced patients and multiply (yes as in multiples of) your available patients as you move to less sick patients. The medical community has been voicing that provenge should logically be used earlier and in time it will be used earlier.

 

[Anonymous]

Fantastic drug. Too bad the criminals were dumb in how they ran the FDA approvals and are still keeping it from saving people.

 

[Anonymous]

Fantastic drug. Too bad the criminals were dumb in how they ran the FDA approvals and are still keeping it from saving people.

sad that it is going to be left to the feds to clean up this mess. that is the only thing that will begin to get this product to end users. BP is the only way provenge even has a chance and nothing happens in that regard until the criminals are separated from the company and the extent of legal liability is known to suitors.

 

[Anonymous]

The Company has a brand new senior management team and the Company will be a success. Provenge already is one of the top ten in oncology drug launches of all time . New management will continue to grow revenues and cut costs.

Too bad that this board has been overun by a gang of idiots from yahoo.

 

[Anonymous]

Thank you for posting the information on Provenge for lower PSA prostate cancer patients. I will pass the information on to my uncle with prostate cancer. I think the information will be useful to him and his urologist.